The company has developed ThyroidPrint, a genetic test for thyroid cancer that has been validated in two independent clinical trials. Geneprodx is a spin-off from the Pontifical Catholic University of Chile and is the first Chilean clinical laboratory accredited by the College of American Patologists (CAP). Patients and physicians can find more information about ThyroidPrint on the company's website.